Recent Comments

Comment RSS

Thiarabine News and Research RSS Feed - Thiarabine News and Research

Thiarabine is a next generation nucleoside analogue. It has been in two Phase 1/2 solid tumor trials and was shown to have significant anti-tumor activity.

Access Pharmaceuticals' update on its European commercial launch of Mugard

15. October 2009 08:49
ACCESS PHARMACEUTICALS, INC. today provided an update on its European commercial launch of MuGard, an FDA approved treatment for oral mucositis, a debilitating side effect of radiation treatment and chemotherapy. [More]

Posted in: Medical Condition News | Pharmaceutical News

Tags: , , , , , , , , , , , , ,

Permalink | Comments (0)

iMedicor to market Access Pharmaceuticals' MuGard in North America

6. October 2009 08:50
ACCESS PHARMACEUTICALS, INC. announced today that it had signed an agreement with iMedicor for the North American commercial launch of MuGard, its FDA approved mucoadhesive oral rinse for the management of oral mucositis and stomatitis caused by radiotherapy and/or chemotherapy. [More]

Posted in: Medical Condition News | Pharmaceutical News

Tags: , , , , , , , , , , , , ,

Permalink | Comments (0)

Accupac to manufacture Access Pharmaceuticals' MuGard

11. September 2009 09:40
ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) has entered into an agreement with a leading commercial manufacturer to produce its FDA-approved MuGard for North American distribution. One or more U.S. market seeding studies could begin as early as Q4 2009, the company says. [More]

Posted in: Medical Condition News | Pharmaceutical News

Tags: , , , , , , , , , , , , , , ,

Permalink | Comments (0)

Update on Prolindac clinical development plan provided by Access Pharmaceuticals

11. September 2009 06:15
ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), provided an update today on the Company's clinical development plan for ProLindac, a novel DACH platinum drug that has shown to be active in many solid tumor types in human clinical studies. [More]

Posted in: Drug Trial News | Pharmaceutical News

Tags: , , , , , , , , , , , , ,

Permalink | Comments (0)

Thiarabine shows promise for rheumatoid arthritis

7. July 2009 22:08
Access Pharmaceuticals, Inc. announced today new preclinical data demonstrating that thiarabine shows remarkable efficacy in the prevention and treatment of rheumatoid arthritis (RA). [More]

Posted in: Drug Trial News

Tags: , , , ,

Permalink | Comments (0)
News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.